Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02745548 · ClinicalTrials.gov registry record
Bronchial Mapping (GCC 1635)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 23
- Enrollment target
NCT02745548 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 23 participants.
The verdict
NCT02745548 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
In order to better understand radiation-induced lung toxicity, the investigator proposes a novel functional avoidance approach that incorporates central as well as peripheral BSS segments in the treatment planning process in order to quantify and account for their respective radiosensitivities. Specifically, the investigator proposes a systematic study that involves acquiring pre- and post-SAbR high-resolution CT and SPECT V/Q scans from lung cancer patients who receive radiotherapy, followed by auto-segmentation of the BSS elements using virtual bronchoscopy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2024-10-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02745548
The ClinicalTrials.gov registry entry for NCT02745548 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02745548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02745548 about?
NCT02745548 is a clinical study titled "Bronchial Mapping (GCC 1635)". In order to better understand radiation-induced lung toxicity, the investigator proposes a novel functional avoidance approach that incorporates central as well as peripheral BSS segments in the treatment planning process in order to quantify and account for their respective radiosensitivities. Spec...
What is the current status of trial NCT02745548?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2017-06-01. Estimated completion is 2024-10-02.
Who is sponsoring clinical trial NCT02745548?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.